PIPELINE

Our pipeline comprises multiple product candidates which are subject to more than 20 ongoing clinical studies in infectious diseases and cancer. Many of our programs are supported by external funding through either private or governmental partnerships.

First quarterly report 2018 (Q1)

May 24, 2018 | Annual/Interim Reports

Bavarian Nordic announced its 2018 first quarter results on Thursday, May 24, 2018.

The management of Bavarian Nordic hosted a conference call on the same day to present the interim results followed by a Q&A session. A live and replay version of the call and relevant slides is available below.

November 7, 2019Financial Statements for the first nine months of 2019 (Q3)

During a period of two weeks before the planned release of its full year or interim financial report, Bavarian Nordic does not comment on matters related to the Group's general financial performance or expectations.